Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Pál Rakonczai"'
Autor:
Lilla Pogácsás, András Borsi, Péter Takács, Éva Remenyik, Lajos Kemény, Sarolta Kárpáti, Péter Holló, Norbert Wikonkál, Rolland Gyulai, Zsuzsanna Károlyi, Pál Rakonczai, Tamás Balázs, Andrea Szegedi
Publikováno v:
Journal of Dermatological Treatment, Vol 28, Iss 7, Pp 635-641 (2017)
Persistence is an important component of therapeutic success, which depends on a variety of factors. Persistence measured under optimal conditions during clinical trials does not necessarily coincide with persistence observed in the real-world settin
Externí odkaz:
https://doaj.org/article/0fafa8efc3984d058dd373fc2e8bc305
Autor:
Odette S. Reifsnider, Ali Tafazzoli, Stephan Linden, Jack Ishak, Pal Rakonczai, Matthew Stargardter, Effie Kuti
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 4 (2024)
Background In the EMPEROR‐Reduced trial (Empagliflozin Outcome Trial in Patients with Chronic Heart Failure and a Reduced Ejection Fraction), empagliflozin plus standard of care reduced the composite of cardiovascular death or hospitalization for h
Externí odkaz:
https://doaj.org/article/8be347aa15bf47fe965fc52f141023d4